Skip to main content
David Rimm, MD, Pathology, New Haven, CT

David L Rimm MD

Pathology•New Haven, CT

Cytopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, Yale University School of Medicine

Join to view full profile

  • 310 Cedar St# LauderNew Haven, CT 06510

  • Phone+1 203-785-3624

  • Fax+1 203-785-7037

Dr. Rimm is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Rimm's full profileAlready have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1989 - 1993
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1989
  • University of Wisconsin-Madison
    University of Wisconsin-MadisonB.S., with Honors, 1977 - 1981

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1992 - 2027
  • Anatomic Pathology
    American Board of Pathology Anatomic Pathology
  • Cytopathology
    American Board of Pathology Cytopathology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2014
  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • America's Top Doctors for Cancer Castle Connolly, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Siglec-15 as an Immune Suppressor and Potential Target for Normalization Cancer Immunotherapy  
    David L Rimm, Agedi N Boto, Roy S Herbst, Nature
  • An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast Cancer  
    Richard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature
  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer  
    Guoping Cai, Sarah B Goldberg, Scott Gettinger, Anne Chiang, Roy S Herbst, David L Rimm, Kurt Schalper, Richard Lifton, Clinical Cancer Research

Books/Book Chapters

  •  
    Chapter: Dabbs’ Immunohistochemistry 
    Pantanowicz L. and Rimm DL2014
  •  
    Chapter: Tissue Microarrays in Cancer 
    Page 26 - 33Dolled-Filhart, M.P. and Rimm, D.L.Editors: DiVita, Rosenberg and Hellman.Edition 7th,2004
  •  
    Chapter: JAKs and STATs as Biomarkers of Disease 
    Dolled-Filhart, M.P. and Rimm, D.L.Editors: Seghal, Levy and Hirano.Kluwer, Armsterdam, The Netherlands2003

Abstracts/Posters

  • Rimm,D.L., San Antonio, TX, 1/8/2011
  • VanHouten, J., Sullivan, C., Bazinet, C., Ryoo, T., Camp, R., Rimm, D.L., Chung, G., and Wysolmerski, J, Proc Natl Acad Sci, 1/1/2010
  • Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT, Proc Natl Acad Sci, 1/1/2009

Lectures

  •  
    Athens, Greece - 1/30/2015
  •  
    Philadelphia, PA - 1/30/2015
  •  
    Bethesda, MD - 1/30/2015

Authored Content

  • HER2-Low, a Separate Entity?December 2022

Press Mentions

  • Multigenerational Yale Legacy Fuels $1 Million for Cancer Research at Yale School of Medicine
    Multigenerational Yale Legacy Fuels $1 Million for Cancer Research at Yale School of MedicineSeptember 16th, 2026
  • David Rimm, MD, PhD, Chosen for Pathology Cancer Research Award
    David Rimm, MD, PhD, Chosen for Pathology Cancer Research AwardApril 10th, 2026
  • Back-to-Back Sessions to Illuminate ADC Complexities, Considerations for Clinical Use
    Back-to-Back Sessions to Illuminate ADC Complexities, Considerations for Clinical UseDecember 10th, 2025

Grant Support

  • Predicting Metastasis In MelanomaNational Cancer Institute2006–2012
  • Shared Resources-Critical Technologies For Tissue ServicesNational Cancer Institute2007–2011
  • Optimal Predictors Of Response To TrastuzumabNational Cancer Institute2009–2010
  • Predicting Metastasis To Lymph NodesNational Cancer Institute2005–2008
  • Prediction Of Breast Cancer Response To Hormonal ThearpyNational Cancer Institute2004–2007

External Links

  • lab pagehttp://medicine.yale.edu/lab/rimm/david_rimm.profile?source=news
  • faculty pagehttp://medicine.yale.edu/pathology/people/david_rimm.profile

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. David Rimm, Dr. David Rimm, MD, Dr. D Rimm, Dr. David L Rimm